OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Abuse Potential of Pregabalin
Ole Schjerning, Mary Rosenzweig, Anton Pottegård, et al.
CNS Drugs (2016) Vol. 30, Iss. 1, pp. 9-25
Closed Access | Times Cited: 130
Ole Schjerning, Mary Rosenzweig, Anton Pottegård, et al.
CNS Drugs (2016) Vol. 30, Iss. 1, pp. 9-25
Closed Access | Times Cited: 130
Showing 1-25 of 130 citing articles:
Pregabalin for neuropathic pain in adults
Sheena Derry, Rae Frances Bell, Sebastian Straube, et al.
Cochrane library (2019)
Open Access | Times Cited: 309
Sheena Derry, Rae Frances Bell, Sebastian Straube, et al.
Cochrane library (2019)
Open Access | Times Cited: 309
How addictive are gabapentin and pregabalin? A systematic review
Udo Bonnet, Norbert Scherbaum
European Neuropsychopharmacology (2017) Vol. 27, Iss. 12, pp. 1185-1215
Closed Access | Times Cited: 233
Udo Bonnet, Norbert Scherbaum
European Neuropsychopharmacology (2017) Vol. 27, Iss. 12, pp. 1185-1215
Closed Access | Times Cited: 233
Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use
Elena P. Calandre, Fernando Rico‐Villademoros, Mahmoud Slim
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 11, pp. 1263-1277
Closed Access | Times Cited: 188
Elena P. Calandre, Fernando Rico‐Villademoros, Mahmoud Slim
Expert Review of Neurotherapeutics (2016) Vol. 16, Iss. 11, pp. 1263-1277
Closed Access | Times Cited: 188
Risk to heroin users of polydrug use of pregabalin or gabapentin
Abigail Lyndon, Suzanne Audrey, Claudia Wells, et al.
Addiction (2017) Vol. 112, Iss. 9, pp. 1580-1589
Open Access | Times Cited: 149
Abigail Lyndon, Suzanne Audrey, Claudia Wells, et al.
Addiction (2017) Vol. 112, Iss. 9, pp. 1580-1589
Open Access | Times Cited: 149
Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines
Arne Reimers, Jon Andsnes Berg, Margrete Larsen Burns, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 271-280
Open Access | Times Cited: 108
Arne Reimers, Jon Andsnes Berg, Margrete Larsen Burns, et al.
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 271-280
Open Access | Times Cited: 108
Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings
Rose Cairns, Andrea L. Schaffer, Nicole Ryan, et al.
Addiction (2018) Vol. 114, Iss. 6, pp. 1026-1034
Closed Access | Times Cited: 93
Rose Cairns, Andrea L. Schaffer, Nicole Ryan, et al.
Addiction (2018) Vol. 114, Iss. 6, pp. 1026-1034
Closed Access | Times Cited: 93
Current Evidence on Abuse and Misuse of Gabapentinoids
Staffan Hägg, Anna K. Jönsson, Johan Ahlner
Drug Safety (2020) Vol. 43, Iss. 12, pp. 1235-1254
Open Access | Times Cited: 86
Staffan Hägg, Anna K. Jönsson, Johan Ahlner
Drug Safety (2020) Vol. 43, Iss. 12, pp. 1235-1254
Open Access | Times Cited: 86
Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France
Damien Driot, Émilie Jouanjus, Stéphane Oustric, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 6, pp. 1260-1269
Open Access | Times Cited: 84
Damien Driot, Émilie Jouanjus, Stéphane Oustric, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 6, pp. 1260-1269
Open Access | Times Cited: 84
European* clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
Winfried Häuser, Bart Morlion, Kevin E. Vowles, et al.
European Journal of Pain (2021) Vol. 25, Iss. 5, pp. 949-968
Open Access | Times Cited: 81
Winfried Häuser, Bart Morlion, Kevin E. Vowles, et al.
European Journal of Pain (2021) Vol. 25, Iss. 5, pp. 949-968
Open Access | Times Cited: 81
Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale
James S. W. Hong, Lauren Atkinson, Noura Al‐Juffali, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1339-1349
Open Access | Times Cited: 71
James S. W. Hong, Lauren Atkinson, Noura Al‐Juffali, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1339-1349
Open Access | Times Cited: 71
The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials
Jawza Meaadi, Ilona Obara, Sam Eldabe, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 3, pp. 556-565
Open Access | Times Cited: 26
Jawza Meaadi, Ilona Obara, Sam Eldabe, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 3, pp. 556-565
Open Access | Times Cited: 26
Diagnosing and treating depression in epilepsy
Christian E. Elger, Samantha A. Johnston, Christian Hoppe
Seizure (2016) Vol. 44, pp. 184-193
Open Access | Times Cited: 77
Christian E. Elger, Samantha A. Johnston, Christian Hoppe
Seizure (2016) Vol. 44, pp. 184-193
Open Access | Times Cited: 77
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
Fabrizio Schifano, Stefania Chiappini, John Corkery, et al.
Brain Sciences (2018) Vol. 8, Iss. 4, pp. 73-73
Open Access | Times Cited: 76
Fabrizio Schifano, Stefania Chiappini, John Corkery, et al.
Brain Sciences (2018) Vol. 8, Iss. 4, pp. 73-73
Open Access | Times Cited: 76
Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report
Thitiporn Supasitthumrong, Blanca Bolea-Alamañac, Selim Asmer, et al.
British Journal of Clinical Pharmacology (2018) Vol. 85, Iss. 4, pp. 690-703
Open Access | Times Cited: 70
Thitiporn Supasitthumrong, Blanca Bolea-Alamañac, Selim Asmer, et al.
British Journal of Clinical Pharmacology (2018) Vol. 85, Iss. 4, pp. 690-703
Open Access | Times Cited: 70
Fatal poisoning in drug addicts in the Nordic countries in 2017
Kirsten Wiese Simonsen, Pirkko Kriikku, Gunilla Thelander, et al.
Forensic Science International (2020) Vol. 313, pp. 110343-110343
Open Access | Times Cited: 60
Kirsten Wiese Simonsen, Pirkko Kriikku, Gunilla Thelander, et al.
Forensic Science International (2020) Vol. 313, pp. 110343-110343
Open Access | Times Cited: 60
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Harry Fagan, David S. Baldwin
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 6, pp. 535-548
Open Access | Times Cited: 21
Harry Fagan, David S. Baldwin
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 6, pp. 535-548
Open Access | Times Cited: 21
Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study
Adrienne Chan, A. Yuen, Daniel Hsiang-Te Tsai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Adrienne Chan, A. Yuen, Daniel Hsiang-Te Tsai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment
Carmen Pastor Gimeno, Marisa Luisa Dorado, Carlos Roncero, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 56
Carmen Pastor Gimeno, Marisa Luisa Dorado, Carlos Roncero, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 56
Oxycodone‐induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition
R. W. Hill, William L. Dewey, Eamonn Kelly, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 12, pp. 2492-2503
Open Access | Times Cited: 49
R. W. Hill, William L. Dewey, Eamonn Kelly, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 12, pp. 2492-2503
Open Access | Times Cited: 49
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review
Rainer Freynhagen, Miroslav Bačkonja, Stephan A. Schug, et al.
CNS Drugs (2016) Vol. 30, Iss. 12, pp. 1191-1200
Open Access | Times Cited: 48
Rainer Freynhagen, Miroslav Bačkonja, Stephan A. Schug, et al.
CNS Drugs (2016) Vol. 30, Iss. 12, pp. 1191-1200
Open Access | Times Cited: 48
Misuse and Mortality Related to Gabapentin and Pregabalin are Being Under-Estimated: A Two-Year Post-Mortem Population Study
Limon Khatun Nahar, Kevin G. Murphy, Sue Paterson
Journal of Analytical Toxicology (2019) Vol. 43, Iss. 7, pp. 564-570
Open Access | Times Cited: 46
Limon Khatun Nahar, Kevin G. Murphy, Sue Paterson
Journal of Analytical Toxicology (2019) Vol. 43, Iss. 7, pp. 564-570
Open Access | Times Cited: 46
Pregabalin misuse: a case report
Seyed Hamzeh Hosseini, Hamed Ghazvini, Seyedeh Masoumeh Seyedhosseini Tamijani, et al.
Journal of Substance Use (2025), pp. 1-4
Closed Access
Seyed Hamzeh Hosseini, Hamed Ghazvini, Seyedeh Masoumeh Seyedhosseini Tamijani, et al.
Journal of Substance Use (2025), pp. 1-4
Closed Access
Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences
Amneh Al-Husseini, Mayyada Wazaify, Marie Claire Van Hout
International Journal of Mental Health and Addiction (2017) Vol. 16, Iss. 3, pp. 642-654
Open Access | Times Cited: 47
Amneh Al-Husseini, Mayyada Wazaify, Marie Claire Van Hout
International Journal of Mental Health and Addiction (2017) Vol. 16, Iss. 3, pp. 642-654
Open Access | Times Cited: 47
Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
Jean‐Baptiste Bossard, Camille Ponté, Julie Dupouy, et al.
Clinical Drug Investigation (2016) Vol. 36, Iss. 9, pp. 735-742
Closed Access | Times Cited: 40
Jean‐Baptiste Bossard, Camille Ponté, Julie Dupouy, et al.
Clinical Drug Investigation (2016) Vol. 36, Iss. 9, pp. 735-742
Closed Access | Times Cited: 40
